OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
Su Jin Jeong, Seung Eun Lee, Dong Hyun Shin, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Su Jin Jeong, Seung Eun Lee, Dong Hyun Shin, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing
Kristen Thompson, Brandi L. Bowers, A. Evans
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 3, pp. 102068-102068
Open Access
Kristen Thompson, Brandi L. Bowers, A. Evans
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 3, pp. 102068-102068
Open Access
Reprint of: Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing
Kristen Thompson, Brandi L. Bowers, A. Evans
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 4, pp. 102177-102177
Closed Access
Kristen Thompson, Brandi L. Bowers, A. Evans
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 4, pp. 102177-102177
Closed Access
Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model
Susanna Joo, Seungwon Yang, Su-Hyun Lee, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1369-1369
Open Access
Susanna Joo, Seungwon Yang, Su-Hyun Lee, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1369-1369
Open Access
Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States
Eugene E. Wright, Susanne B. Nicholas
Postgraduate Medicine (2024) Vol. 136, Iss. 4, pp. 347-357
Open Access
Eugene E. Wright, Susanne B. Nicholas
Postgraduate Medicine (2024) Vol. 136, Iss. 4, pp. 347-357
Open Access
Prevalence of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitor Prescribing in Patients with Type 2 Diabetes Mellitus and Reduced Estimated Glomerular Filtration Rate
Kayla Chonko, Giavanna Russo‐Alvarez, Diana Isaacs, et al.
INNOVATIONS in pharmacy (2023) Vol. 14, Iss. 2, pp. 9-9
Open Access | Times Cited: 1
Kayla Chonko, Giavanna Russo‐Alvarez, Diana Isaacs, et al.
INNOVATIONS in pharmacy (2023) Vol. 14, Iss. 2, pp. 9-9
Open Access | Times Cited: 1
Assessment of Knowledge and Perception of Sodium-Glucose Co-transporter 2 (SGLT-2) Inhibitors Prescription among Physicians in Saudi Arabia
Mohammed Somaili, Omar Oraibi, Majed Darraj, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 1
Mohammed Somaili, Omar Oraibi, Majed Darraj, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 1
Sodium Glucose Co-Transporter 2 Inhibitors and the Cardiovascular System: Current Knowledge and Future Expectations
Ioannis Boutsikos, Eleftherios Beltsios, Bastian Schmack, et al.
Heart International (2023) Vol. 17, Iss. 2, pp. 12-12
Open Access | Times Cited: 1
Ioannis Boutsikos, Eleftherios Beltsios, Bastian Schmack, et al.
Heart International (2023) Vol. 17, Iss. 2, pp. 12-12
Open Access | Times Cited: 1
Improving kidney protection in patients with type 2 diabetes
Annemarie van der Aart-van der Beek
(2023)
Open Access
Annemarie van der Aart-van der Beek
(2023)
Open Access
Improving care practices of the patient with type 2 diabetes in community health centers
D. Slade, Kayla Carr, Masoumeh Karimi, et al.
Journal of the American Association of Nurse Practitioners (2023) Vol. 36, Iss. 2, pp. 128-135
Closed Access
D. Slade, Kayla Carr, Masoumeh Karimi, et al.
Journal of the American Association of Nurse Practitioners (2023) Vol. 36, Iss. 2, pp. 128-135
Closed Access
Use of Sodium–glucose Cotransporter 2 Inhibitors in Patients with Chronic Kidney Disease
Ahmed M. Alkhunaizi, Hanan Khairalla
Saudi Journal of Kidney Diseases and Transplantation (2023) Vol. 34, Iss. 5, pp. 468-473
Open Access
Ahmed M. Alkhunaizi, Hanan Khairalla
Saudi Journal of Kidney Diseases and Transplantation (2023) Vol. 34, Iss. 5, pp. 468-473
Open Access
Effects of Sodium-Glucose Cotransporter-2 Inhibitors and Thiazolidinedione on New-Onset Atrial Fibrillation Risk to Patients with Type 2 Diabetes
Hae‐Geun Song, Yoo Ri Kim, Seung Eun Lee, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 9
Open Access
Hae‐Geun Song, Yoo Ri Kim, Seung Eun Lee, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 9
Open Access
Are Our Type 2 Diabetes Patients Sufficiently Protected from Cardiorenal Complications
Goh Su-Yen
The Singapore Family Physician (2021) Vol. 47, Iss. 8, pp. 5-8
Closed Access
Goh Su-Yen
The Singapore Family Physician (2021) Vol. 47, Iss. 8, pp. 5-8
Closed Access
Are Our Type 2 Diabetes Patients Sufficiently Protected from Cardiorenal Complications?
Prof Goh
The Singapore Family Physician (2021) Vol. 47, Iss. 8
Open Access
Prof Goh
The Singapore Family Physician (2021) Vol. 47, Iss. 8
Open Access
